Dyadic International vs Evogene
Evogene is the larger business, with $3.9m of revenue in fiscal 2025 against $3.1m for Dyadic International (1.2 times as much). Dyadic International grew faster (-11.6% against -30.9%). Evogene kept more of each dollar of sales as profit: a net margin of -220.2% against -238.3%.
| Latest fiscal year | Dyadic InternationalDYAI, 2025 | EvogeneEVGN, 2025 |
|---|---|---|
| Revenue | $3.1m | $3.9m |
| Revenue growth | -11.6% | -30.9% |
| Net income | −$7.4m | −$8.5m |
| Operating margin | -232.8% | -364.2% |
| Net margin | -238.3% | -220.2% |
| Return on equity | — | — |
| Free cash flow | — | −$13.6m |
| Cash | $4.6m | $13.0m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 5 | — |
| Market value | $13.2m | $3.1m |
| Price vs our value range | — | — |
| Moat score | 8 (Weak) | — |
| Insider trades, 12 months | 0 buys, 3 sales | 3 buys, 0 sales |